Advances in animal cell recombinant protein production: GS-NS0 expression system

The production of recombinant proteins using mammalian cell expression systems is of growing importance within biotechnology, largely due to the ability of specific mammalian cells to carry out post-translational modifications of the correct fidelity. The Glutamine Synthetase-NS0 system is now one such industrially important expression system.Glutamine synthetase catalyses the formation ofglutamine from glutamate and ammonia. NS0 cellscontain extremely low levels of endogenous glutaminesynthetase activity, therefore exogenous glutaminesynthetase can be used efficiently as a selectablemarker to identify successful transfectants in theabsence of glutamine in the media. In addition, theinclusion of methionine sulphoximine, an inhibitor ofglutamine synthetase activity, enables furtherselection of those clones producing relatively highlevels of transfected glutamine synthetase and henceany heterologous gene which is coupled to it. Theglutamine synthetase system technology has been usedfor research and development purposes during thisdecade and its importance is clearly demonstrated nowthat two therapeutic products produced using thissystem have reached the market place.

[1]  J. Trowsdale,et al.  The LFA‐3 Adhesion Pathway is Differently Utilized by Superantigen‐Activated Human CD4+ T‐Cell Subsets , 1992, Scandinavian journal of immunology.

[2]  P. Tsai,et al.  Product Consistency During Long-Term Fed-Batch Culture , 1994 .

[3]  M. Cockett,et al.  The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines. , 1991, Nucleic acids research.

[4]  R. Owens,et al.  Expression, purification and characterization of B72.3 Fv fragments. , 1993, The Biochemical journal.

[5]  E. Garvey,et al.  High-level expression of human inducible nitric oxide synthase in Chinese hamster ovary cells and characterization of the purified enzyme. , 1996, Biochemical and biophysical research communications.

[6]  M J Keen,et al.  Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. , 1995, Glycobiology.

[7]  R. Dwek,et al.  Site-specific glycosylation of recombinant rat and human soluble CD4 variants expressed in Chinese hamster ovary cells. , 1993, The Journal of biological chemistry.

[8]  Zhong Liu,et al.  Rapid establishment of high-producing cell lines using dicistronic vectors with glutamine synthetase as the selection marker , 1998, Molecular biotechnology.

[9]  J. O'Connell,et al.  The role of the C-terminal domain in collagenase and stromelysin specificity. , 1992, The Journal of biological chemistry.

[10]  Brown Mh,et al.  Expression of immunoglobulin and scavenger receptor superfamily domains as chimeric proteins with domains 3 and 4 of CD4 for ligand analysis , 1994 .

[11]  A. Cloeckaert,et al.  Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115. , 1993, Journal of general microbiology.

[12]  M. Glennie,et al.  Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma. , 1995, Journal of immunology.

[13]  D K Robinson,et al.  Characterization of a recombinant antibody produced in the course of a high yield fed‐batch process , 1994, Biotechnology and bioengineering.

[14]  N. Hogg,et al.  Antibodies that activate β2 integrins can generate different ligand binding states , 1995, European journal of immunology.

[15]  F. Jakob,et al.  Characterization of five monoclonal antibodies raised against domain E of the porcine estradiol receptor. , 2009, Experimental and clinical endocrinology.

[16]  A. Cloeckaert,et al.  O-chain expression in the rough Brucella melitensis strain B115: induction of O-polysaccharide-specific monoclonal antibodies and intracellular localization demonstrated by immunoelectron microscopy. , 1992, Journal of general microbiology.

[17]  S. Latt,et al.  Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells , 1985, Molecular and cellular biology.

[18]  C. Simonsen,et al.  The molecular biology of production cell lines. , 1994, Biologicals : journal of the International Association of Biological Standardization.

[19]  R. Field,et al.  Selecting and designing cell lines for improved physiological characteristics , 2004, Cytotechnology.

[20]  P. Bjorkman,et al.  Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Stuart,et al.  Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. , 1993, Protein engineering.

[22]  C. Milstein,et al.  Possible role for the Fc receptor on B lymphocytes , 1974, Nature.

[23]  P. Johnson,et al.  Structure and function of CD45: a leukocyte-specific protein tyrosine phosphatase. , 1992, Advances in experimental medicine and biology.

[24]  J. Moore,et al.  Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. , 1990, AIDS.

[25]  R. L. Hawkins,et al.  Lactate: A major product of glutamine metabolism by human diploid fibroblasts , 1980, Journal of cellular physiology.

[26]  N. Proudfoot Transcriptional interference and termination between duplicated α-globin gene constructs suggests a novel mechanism for gene regulation , 1986, Nature.

[27]  M. Doyle,et al.  THE DEVELOPMENT OF A PROCESS FOR THE PRODUCTION OF HIV1 GP120 FROM RECOMBINANT CELL LINES , 1991 .

[28]  C. Bebbington,et al.  Control of growth and recombinant protein synthesis by heat-shock in a mutant mammalian cell line , 1994, Biotechnology Letters.

[29]  L. Levintow,et al.  Reversibility of the enzymatic synthesis of glutamine. , 1954, The Journal of biological chemistry.

[30]  M. Massaer,et al.  Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells. , 1996, Virus research.

[31]  B. Buckland,et al.  Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. , 1997, Biotechnology and bioengineering.

[32]  J. Wienberg,et al.  Amplified expression constructs for human tissue-type plasminogen activator in Chinese hamster ovary cells: instability in the absence of selective pressure. , 1988, Gene.

[33]  D R Burton,et al.  Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.

[34]  S. Nussey,et al.  The use of the amplifiable high-expression vector pEE14 to study the interactions of autoantibodies with recombinant human thyrotrophin receptor , 1992, Molecular and Cellular Endocrinology.

[35]  J. F. Speck The enzymic synthesis of glutamine. , 1947, The Journal of biological chemistry.

[36]  J. Kearney,et al.  Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein , 1987, The Journal of cell biology.

[37]  D. James,et al.  Real-time monitoring of recombinant protein concentration in animal cell cultures using an optical biosensor , 1997 .

[38]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[39]  A. Barclay,et al.  The hinge region of the CD8 alpha chain: structure, antigenicity, and utility in expression of immunoglobulin superfamily domains. , 1992, International immunology.

[40]  J. Cyster,et al.  The NH2‐terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2 , 1993, European journal of immunology.

[41]  M. Silberklang,et al.  Structural characterization of the N-glycans of a humanized anti-CD18 murine immunoglobulin G. , 1994, Archives of biochemistry and biophysics.

[42]  R. Owens,et al.  Interaction of the low-affinity receptor CD23/Fc epsilonRII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E. , 1997, Biochemistry.

[43]  A. Meister 23. Glutamine Synthetase of Mammals , 1974 .

[44]  P. Slocombe,et al.  The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. , 1993, Biochemistry.

[45]  C. Milstein,et al.  Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell lines , 1976, European journal of immunology.

[46]  G. Moore,et al.  The effect of dihydrofolate reductase-mediated gene amplification on the expression of transfected immunoglobulin genes. , 1987, Journal of immunology.

[47]  H. Pu,et al.  The structure of the chicken glutamine synthetase-encoding gene. , 1989, Gene.

[48]  S. Nussey,et al.  Interaction of thyrotropin and thyroid-stimulating antibodies with recombinant extracellular region of human TSH receptor , 1992, The Lancet.

[49]  M. Silberklang,et al.  Optimization of a Fed‐batch Process for Production of a Recombinant Antibody , 1994, Annals of the New York Academy of Sciences.

[50]  E. Padlan,et al.  A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties. , 1997, AIDS research and human retroviruses.

[51]  W. Zhang,et al.  Identification of functional domains on gC1Q-R, a cell surface protein that binds to the globular "heads" of C1Q, using monoclonal antibodies and synthetic peptides. , 1996, Hybridoma.

[52]  R. Owens,et al.  Secretion of recombinant human IgE-Fc by mammalian cells and biological activity of glycosylation site mutants. , 1995, Protein engineering.

[53]  E. Butcher,et al.  Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. , 1992, Journal of immunology.

[54]  T. Deuel,et al.  Regulation of glutamine synthetase by dexamethasone in hepatoma tissue culture cells. , 1978, The Journal of biological chemistry.

[55]  R. Field,et al.  Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system , 2006, Cytotechnology.

[56]  P. Bjorkman,et al.  Effects of peptide length and composition on binding to an empty class I MHC heterodimer. , 1994, Biochemistry.

[57]  A. F. Williams,et al.  Structural diversity in domains of the immunoglobulin superfamily. , 1989, Cold Spring Harbor symposia on quantitative biology.

[58]  A. Meister 1 – Catalytic Mechanism of Glutamine Synthetase; Overview of Glutamine Metabolism , 1980 .

[59]  H. Wong,et al.  Single-chain MHC class II molecules induce T cell activation and apoptosis. , 1996, Journal of immunology.

[60]  L. Cavaleri,et al.  Purification and properties of insulin receptor ectodomain from large-scale mammalian cell culture. , 1995, Protein expression and purification.

[61]  M. Butler,et al.  Nutritional aspects of the growth of animal cells in culture , 1989 .

[62]  M. Potter,et al.  Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants , 1962, Nature.

[63]  T. Kadesch,et al.  Effects of the position of the simian virus 40 enhancer on expression of multiple transcription units in a single plasmid , 1986, Molecular and cellular biology.

[64]  N. Jenkins,et al.  Generation of CHO Cell Mutants for Growth Control , 1993 .

[65]  B. Davis,et al.  NMR analysis of the N-terminal SRCR domain of human CD5: engineering of a glycoprotein for superior characteristics in NMR experiments. , 1998, Protein engineering.

[66]  M. Potter,et al.  HISTOLOGY OF DEVELOPING PLASMA CELL NEOPLASIA INDUCED BY MINERAL OIL IN BALB/C MICE. , 1964, Journal of the National Cancer Institute.

[67]  C. McInnes,et al.  The cloning and expression of the gene for ovine interleukin-3 (multi-CSF) and a comparison of the in vitro hematopoietic activity of ovine IL-3 with ovine GM-CSF and human M-CSF. , 1993, Experimental hematology.

[68]  E. Appella,et al.  Variations in the heavy polypeptide chain structure of gamma myeloma immunoglobulins from an inbred strain of mice and a hypothesis as to their origin. , 1965, Journal of molecular biology.

[69]  M. Zhu,et al.  Immunoglobulin variable region hypermutation in hybrids derived from a pre-B- and a myeloma cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[70]  D. Gewert,et al.  Expression and purification of recombinant, glycosylated human interferon alpha 2b in murine myeloma NSo cells. , 1996, Protein expression and purification.

[71]  K. Gull,et al.  NSO myeloma cell death: Influence of bcl‐2 overexpression , 1996, Biotechnology and bioengineering.

[72]  E. Berg,et al.  Antibodies cross-reactive with E- and P-selectin block both E- and P-selectin functions. , 1995, Blood.

[73]  W. H. Elliott Adenosinetriphosphate in Glutamine Synthesis , 1948, Nature.

[74]  R. Miller,et al.  Regulation of glutamine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibutyryl cyclic AMP. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[75]  M. Lockyer,et al.  A humanized CD18 antibody can block function without cell destruction. , 1993, Journal of Immunology.

[76]  E. Carafoli,et al.  Isolation and Characterization of a Stable Chinese Hamster Ovary Cell Line Overexpressing the Plasma Membrane Ca2+-ATPase (*) , 1995, The Journal of Biological Chemistry.

[77]  C. Milstein,et al.  [1] Preparation of monoclonal antibodies: Strategies and procedures , 1981 .

[78]  A. Johnstone,et al.  Characterization of the glutamine synthetase amplifiable eukaryotic expression system applied to an integral membrane protein--the human thyrotropin receptor. , 1992, Analytical biochemistry.

[79]  R. Kucherlapati,et al.  Introduction of purified genes into mammalian cells. , 1984, CRC critical reviews in biochemistry.

[80]  R. Field,et al.  The Production of Recombinant Antibodies Using the Glutamine Synthetase (GS) System , 1993 .

[81]  M. Castro,et al.  Effect of the corticotrophin releasing hormone precursor on interleukin-6 release by human mononuclear cells. , 1997, Clinical immunology and immunopathology.

[82]  N. Jenkins,et al.  Temperature control of growth and productivity in mutant Chinese hamster ovary cells synthesizing a recombinant protein , 1993, Biotechnology and bioengineering.

[83]  R. Williamson,et al.  Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13. , 1992, Biochemistry.

[84]  M. Feany,et al.  The synaptic vesicle proteins SV2, synaptotagmin and synaptophysin are sorted to separate cellular compartments in CHO fibroblasts , 1993, The Journal of cell biology.

[85]  G. Murshudov,et al.  Crystal structure of an extracellular fragment of the rat CD4 receptor containing domains 3 and 4. , 1994, Structure.

[86]  S. Gloor,et al.  Production and secretion in CHO cells of the extracellular domain of AMOG/beta 2, a type-II membrane protein. , 1992, Gene.

[87]  S. Nussey,et al.  Characterization of the extracellular region of the human thyrotrophin receptor expressed as a recombinant protein. , 1992, Journal of molecular endocrinology.

[88]  A. Nesbitt,et al.  Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. , 1995, Immunology.

[89]  A R Flesher,et al.  Fluorophore‐labeled carbohydrate analysis of immunoglobulin fusion proteins: Correlation of oligosaccharide content with in vivo clearance profile , 1995, Biotechnology and bioengineering.

[90]  M. Cockett,et al.  The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. , 1992, The Biochemical journal.

[91]  M. Page Expression of foreign genes in Mammalian cells. , 1988, Methods in molecular biology.

[92]  A. Tsarbopoulos,et al.  Expression, Purification, and Characterization of Recombinant Human Interleukin-13 from NS-0 Cells☆ , 1998 .

[93]  N. G. Ray,et al.  Large-Scale Production of Humanized Monoclonal Antibody Expressed in a GS-NSO Cell Line , 1997 .

[94]  E. M. Tucker,et al.  The production of equine monoclonal immunoglobulins by horse-mouse heterohybridomas. , 1992, Veterinary immunology and immunopathology.

[95]  N. Hogg,et al.  The I Domain of Integrin LFA-1 Interacts with ICAM-1 Domain 1 at Residue Glu-34 but Not Gln-73* , 1998, The Journal of Biological Chemistry.

[96]  C. Bebbington,et al.  Expression of antibody genes in nonlymphoid mammalian cells , 1991 .

[97]  B. Buckland,et al.  Monoclonal Antibody Process Development Using Medium Concentrates , 1994, Biotechnology progress.

[98]  D. Shotton,et al.  Structural analysis of the CD5 antigen--expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1. , 1998, European journal of biochemistry.

[99]  M. J. Keen,et al.  Adaptation of cholesterol-requiring NS0 mouse myeloma cells to high density growth in a fully defined protein-free and cholesterol-free culture medium , 1995, Cytotechnology.

[100]  J. Gray,et al.  Effects of methotrexate on transfected DNA stability in mammalian cells , 1990, Molecular and cellular biology.

[101]  J. Hodgson Expression Systems: A User's Guide , 1993, Bio/Technology.

[102]  Y. Henis,et al.  Effects of exposure to low pH on the lateral mobility of influenza hemagglutinin expressed at the cell surface: correlation between mobility inhibition and inactivation. , 1993, Biochemistry.

[103]  H. Marsden,et al.  Production and characterization of monoclonal antibodies to cervine herpesvirus-1. , 1992, Veterinary microbiology.

[104]  W. Harris,et al.  A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections. , 1997, The Journal of infectious diseases.

[105]  B. Olsen,et al.  The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. , 1996, The Journal of biological chemistry.

[106]  S. R. Max,et al.  Glutamine regulates glutamine synthetase expression in skeletal muscle cells in culture , 1990, Journal of cellular physiology.

[107]  William Arbuthnot Sir Lane,et al.  The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.

[108]  B. Buckland,et al.  Investigation of NS0 Cell Metabolic Behavior in Monoclonal Antibody Producing Clones , 1994, Annals of the New York Academy of Sciences.

[109]  F. Hirayama,et al.  Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture. , 1994, Blood.

[110]  D. Pfarr,et al.  Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. , 1997, The Journal of infectious diseases.

[111]  C. Milstein,et al.  Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: detection of inactive light-chain messenger RNA. , 1974, Journal of molecular biology.

[112]  C. Milstein,et al.  Preparation of monoclonal antibodies: strategies and procedures. , 1981, Methods in enzymology.

[113]  W. H. Elliott Studies on the enzymic synthesis of glutamine. , 1951, The Biochemical journal.

[114]  R. Owens,et al.  Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy. , 1995, British Journal of Cancer.

[115]  M. Cockett,et al.  High Level Expression of Tissue Inhibitor of Metalloproteinases in Chinese Hamster Ovary Cells Using Glutamine Synthetase Gene Amplification , 1990, Bio/Technology.

[116]  P. Roughley,et al.  Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. , 1993, The Biochemical journal.

[117]  M. Page,et al.  High Level Expression of the Humanized Monoclonal Antibody CAMPATH-1H in Chinese Hamster Ovary Cells , 1991, Bio/Technology.

[118]  J. Innes,et al.  Variation in IgG1 heavy chain allotype does not contribute to differences in biological activity of two human anti-Rhesus (D) monoclonal antibodies. , 1998, Immunotechnology : an international journal of immunological engineering.

[119]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[120]  M. Cockett,et al.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). , 1991, The Biochemical journal.

[121]  Y. Henis,et al.  GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity , 1993, The Journal of cell biology.

[122]  N. Siemers,et al.  Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation. , 1997, Bioconjugate chemistry.

[123]  K B Konstantinov,et al.  Monitoring and control of the physiological state of cell cultures. , 2000, Biotechnology and bioengineering.

[124]  M. Rhodes,et al.  Production of recombinant proteins in serum-free media , 2004, Cytotechnology.

[125]  W. Wooster,et al.  Crystal structure of , 2005 .

[126]  M. J. Keen,et al.  The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker , 2004, Cytotechnology.

[127]  D. King,et al.  High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker , 1992, Bio/Technology.

[128]  A. Persson,et al.  Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly. , 1994, The Journal of biological chemistry.

[129]  A. Meister,et al.  Studies on the mechanism of inhibition of glutamine synthetase by methionine sulfoximine. , 1969, Biochemistry.

[130]  S. Mercille,et al.  Induction of apoptosis in oxygen-deprived cultures of hybridoma cells , 1994 .

[131]  P. Tomasec,et al.  Expression of Biologically Active Procorticotrophin‐Releasing Hormone (proCRH) in Stably Transfected CHO‐K1 Cells: Characterization of Nuclear proCRH , 1995, Journal of neuroendocrinology.

[132]  D. Shotton,et al.  Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies. , 1992, Immunology.

[133]  A. Meister,et al.  Inhibition of glutamine synthetase by methionine sulfoximine. Studies on methionine sulfoximine phosphate. , 1969, Biochemistry.

[134]  C. Milstein,et al.  Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion , 1976, European journal of immunology.

[135]  A. Meister,et al.  Identification of L-methionine S-sulfoximine as the diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase. , 1969, Biochemistry.

[136]  Weichang Zhou,et al.  Large scale production of recombinant mouse and rat growth hormone by fed-batch GS-NSO cell cultures , 2004, Cytotechnology.

[137]  A. W. Harris,et al.  Mouse myelomas and lymphomas in culture. , 1970, Experimental cell research.

[138]  T. Lee,et al.  Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. , 1997, Gene.

[139]  I. A. Rose,et al.  A stereochemical method for detection of ATP terminal phosphate transfer in enzymatic reactions. Glutamine synthetase. , 1976, The Journal of biological chemistry.

[140]  S. Prusiner,et al.  Prion protein expression in Chinese hamster ovary cells using a glutamine synthetase selection and amplification system. , 1997, Protein engineering.

[141]  P. Tomasec,et al.  Mitogenic effects and nuclear localisation of procorticotrophin-releasing hormone expressed within stably transfected fibroblast cells (CHO-K1) , 1995, Molecular and Cellular Endocrinology.

[142]  L. Callegaro,et al.  Production of novel monoclonal antibodies against rabbit platelet factor four. , 1992, Hybridoma.

[143]  L. Chasin,et al.  Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[144]  W. Farrell,et al.  Endoplasmic reticulum protein expression in recombinant NS0 myelomas grown in batch culture. , 2000, Biotechnology and bioengineering.

[145]  J. F. Speck The enzymatic synthesis of glutamine, a reaction utilizing adenosine triphosphate. , 1949, The Journal of biological chemistry.

[146]  T. Nakaki,et al.  Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1) , 1989, Molecular and cellular biology.

[147]  R. Lechler,et al.  Use of a murine T-cell hybridoma expressing human T-cell receptor α- and β-gene products as a tool for the production of human T-cell receptor-specific monoclonal antibodies , 1992 .

[148]  A. Barclay,et al.  High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. , 1990, The Journal of biological chemistry.

[149]  C. López-Otín,et al.  Biochemical Characterization of Human Collagenase-3 (*) , 1996, The Journal of Biological Chemistry.

[150]  K. Elkon,et al.  Separate Domains of the Human Fas Ligand Dictate Self-association and Receptor Binding* , 1997, The Journal of Biological Chemistry.

[151]  B. Classon,et al.  Biochemical and immunological properties of rat recombinant interleukin-2 and interleukin-4. , 1992, Immunology.

[152]  S. Narula,et al.  Characterization of Recombinant Extracellular Domain of Human Interleukin-10 Receptor (*) , 1995, The Journal of Biological Chemistry.

[153]  Hans Marquardt,et al.  βig-h3: A Transforming Growth Factor-β-Responsive Gene Encoding a Secreted Protein That Inhibits Cell Attachment In Vitro and Suppresses the Growth of CHO Cells in Nude Mice , 1994 .

[154]  A. Meister,et al.  Phosphorylation of methionine sulfoximine by glutamine synthetase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[155]  R. Williamson,et al.  The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. , 1991, Biochemistry.

[156]  D. Robinson,et al.  Feeding of nutrients delays apoptotic death in fed-batch cultures of recombinant NSO myeloma cells , 1996, Biotechnology Letters.